

Scale & Diversity
Value Through Partnership
UK: becoming a beacon destination for clinical trials

Experts in recruiting patients and running clinical trials - an exemplar SMO model
"We are a team of experienced clinical trial specialists who have held very senior roles in organisations which have pioneered the recruitment and running of clincial trials across the world."
Dr. Ian Smith
Founder of Synexus & Co-Founder of Panthera Biopartners
Our dedicated Panthera clinical trial sites located across the UK.
We have a huge reach in Britain's highest populated cities:
Glasgow | London | Manchester | Preston | Sheffield
Patient testimonials
Latest Panthera News
Speeding up trial enrolment can save billions
New data show that the site management model reduces start-up times for a Phase II or Phase III clinical trial by up to nine months compared to UK public sites, representing billions in savings Panthera identifies likely patients seven months before public sector sites start planning their recruitment campaigns. The loss of nine months patent
Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion
Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe Panthera Biosciences (Panthera) has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment will allow Panthera to further grow its network of dedicated
Panthera partnership with Preston North End Community Trust
Panthera have formed a partnership with Preston North End Football Club Community Trust. The team at Panthera attended the PNE vs Birmingham City game on the 15th of January promoting clinical trials. Fans who visited the Panthera van on game day also learnt more about additional clinical trials, such as those aimed at combating Osteoarthritis and Cardiovascular